PharmaBoardroom

Interview: Ignacio Pino – President, CDI Laboratories Inc.…

Ignacio Pino, president of CDI Laboratories Inc., discusses how his novel technology platform Hu-Prot will help pharmaceutical companies and academia…

Interview: Onder Isinay – General Manager, Biocodex Turkey

Biocodex’s new general manager gives an overview of the affiliates ‘new deal’ program, and how the company has adjusted its approach to better…

Interview: Frank Rodríguez – General Manager, Allergan…

Frank Rodríguez, General Manager for Allergan Operations in Puerto Rico, discusses cost-competitiveness at his plants in Fajardo and Manatí, which…

Interview: Süha Taşpolatoğlu – CEO, Abdi Ibrahim…

Turkey’s leading pharmaceutical company is in the process of developing production facilities abroad, and it has just begun construction of a USD…

Korea: Can High R&D Spending Lead To Commercial Success?

Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist…

How can Korea’s chaebols influence global biotech and pharma…

Korea’s economy has been dominated for decades by chaebols, large family-owned business conglomerates like Samsung, Hyundai, and LG, known for their…

Interview: Jung Hyun Ho – Founder & CEO, Medytox – Korea

Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow…

Interview: Dogan Taşkent – President, Swiss Chamber of…

Dogan Taşkent, president of the Swiss Chamber of Commerce in Turkey discusses the most successful models for innovation in Turkey, the current status…